Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis.

MLA

Yanagisawa, Kiyoshi, et al. “Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis.” International Journal of Proteomics, Jan. 2012, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2012/510397.

APA

Yanagisawa, K., Tomida, S., Matsuo, K., Arima, C., Kusumegi, M., Yokoyama, Y., Ko, S. B. H., Mizuno, N., Kawahara, T., Kuroyanagi, Y., Takeuchi, T., Goto, H., Yamao, K., Nagino, M., Tajima, K., & Takahashi, T. (2012). Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis. International Journal of Proteomics, 1–11. https://doi.org/10.1155/2012/510397

Chicago

Yanagisawa, Kiyoshi, Shuta Tomida, Keitaro Matsuo, Chinatsu Arima, Miyoko Kusumegi, Yukihiro Yokoyama, Shigeru B. H. Ko, et al. 2012. “Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis.” International Journal of Proteomics, January, 1–11. doi:10.1155/2012/510397.